Importance de l'infiltrat immunitaire initial dans l'évaluation, p.65 ,
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer, Oncotarget, vol.6, issue.32, p.32561, 2015. ,
DOI : 10.18632/oncotarget.4935
Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews Cancer, vol.20, issue.11, 2007. ,
DOI : 10.1016/j.urolonc.2006.09.018
Challenges in circulating tumour cell research, 2014. ,
Global surveillance of cancer survival: analysis of individual data for 25 676 887 patients from 279 populationbased registries in 67 countries (CONCORD-2) The Lancet 385, pp.977-1010, 1995. ,
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors, JNCI Journal of the National Cancer Institute, vol.86, issue.11, pp.829-835, 1994. ,
DOI : 10.1093/jnci/86.11.829
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer, Clinical Cancer Research, vol.20, issue.7, pp.1891-1899, 2014. ,
DOI : 10.1158/1078-0432.CCR-13-2830
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, The Lancet Oncology, vol.16, issue.8, pp.919-927, 2015. ,
DOI : 10.1016/S1470-2045(15)00120-5
Local recurrence following total mesorectal excision for rectal cancer, British Journal of Surgery, vol.341, issue.3, pp.375-379, 1996. ,
DOI : 10.1002/bjs.1800830326
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer, British Journal of Cancer, vol.63, issue.2, pp.501-509, 2014. ,
DOI : 10.1084/jem.20121416
Organ Preservation for Rectal Cancer, Journal of Clinical Oncology, vol.25, issue.8, pp.1014-1020, 2007. ,
DOI : 10.1200/JCO.2006.09.7840
Functional Outcome After Coloanal Versus Low Colorectal Anastomosis for Rectal Carcinoma, Journal of the American College of Surgeons, vol.185, issue.2, 1997. ,
DOI : 10.1016/S1072-7515(97)00016-1
The prognostic impact of anti-cancer immune response: a novel classification of cancer patients, Seminars in Immunopathology, vol.27, issue.4, pp.335-340, 2011. ,
DOI : 10.1200/JCO.2008.21.1540
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer, Immunity, vol.39, issue.4, pp.782-795, 2013. ,
DOI : 10.1016/j.immuni.2013.10.003
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer, Immunity, vol.39, issue.4, pp.782-795, 2013. ,
DOI : 10.1016/j.immuni.2013.10.003
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer, Frontiers in Oncology, vol.9, issue.8, 2015. ,
DOI : 10.1186/s13014-014-0295-2
Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results???EORTC 22921, Journal of Clinical Oncology, vol.23, issue.24, pp.5620-5627, 2005. ,
DOI : 10.1200/JCO.2005.02.113
[Epidemiology of colorectal cancer], Rev. Prat, vol.65, pp.767-773, 2015. ,
Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study, International Journal of Cancer, vol.15, issue.5 Suppl, 2012. ,
DOI : 10.1245/s10434-008-0015-y
Colorectal cancer, The Lancet, vol.383, issue.9927, pp.1490-502, 2014. ,
DOI : 10.1016/S0140-6736(13)61649-9
URL : https://hal.archives-ouvertes.fr/hal-01404971
The Concept of Immunological Surveillance, pp.1-27, 1970. ,
DOI : 10.1159/000386035
Cancer--A Biological Approach: III. Viruses Associated with Neoplastic Conditions. IV. Practical Applications, BMJ, vol.1, issue.5023, pp.841-847, 1957. ,
DOI : 10.1136/bmj.1.5023.841
IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS, British Medical Bulletin, vol.20, issue.2, pp.154-158, 1964. ,
DOI : 10.1093/oxfordjournals.bmb.a070310
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy, Pathology - Research and Practice, vol.212, issue.12, pp.1133-1137, 2016. ,
DOI : 10.1016/j.prp.2016.09.012
P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer, PLoS ONE, vol.7, issue.9, p.45388, 2012. ,
DOI : 10.1371/journal.pone.0045388.t003
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA, Annals of Surgery, vol.14, pp.199-220, 1891. ,
DOI : 10.1097/00000658-189112000-00015
Patients With Curative Resection of cT3-4 Rectal Cancer After Preoperative Radiotherapy or Radiochemotherapy: Does Anybody Benefit From Adjuvant Fluorouracil-Based Chemotherapy? A Trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group, J. Clin. Oncol, vol.25, pp.4379-4386, 2007. ,
A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas, The Journal of Experimental Medicine, vol.162, issue.1, pp.119-127, 2002. ,
DOI : 10.1093/intimm/8.11.1759
Clinical Trials Integrating Immunotherapy and Radiation for Non???Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.12, pp.1685-1693, 2015. ,
DOI : 10.1097/JTO.0000000000000686
Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer, American Journal of Clinical Oncology, vol.29, issue.3, pp.219-224, 2006. ,
DOI : 10.1097/01.coc.0000214930.78200.4a
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer, Cancer, vol.194, issue.9, pp.1750-1755, 2007. ,
DOI : 10.1016/0360-3016(94)90359-X
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer, International Journal of Molecular Sciences, vol.9, issue.3, 2017. ,
DOI : 10.1016/j.ctrv.2015.06.007
Dictionnaire d'anatomie, 2006. ,
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer, J, 2010. ,
Microsatellite Instability as a Biomarker for PD-1 Blockade, Clinical Cancer Research, vol.22, issue.4, pp.813-820, 2016. ,
DOI : 10.1158/1078-0432.CCR-15-1678
Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.93, issue.11, pp.991-998, 2002. ,
DOI : 10.1073/pnas.93.21.11798
Interferons, immunity and cancer immunoediting, Nature Reviews Immunology, vol.313, issue.11, pp.836-848, 2006. ,
DOI : 10.1126/science.1129139
Pathological features of rectal cancer after preoperative radiochemotherapy, International Journal of Colorectal Disease, vol.12, issue.1, pp.19-23, 1997. ,
DOI : 10.1007/s003840050072
Über den jetzigen Stand der Karzinomforschung, Beiträge zur experimentellen Pathologie und Chemotherapie, pp.117-164, 1909. ,
The Collected Papers of Paul Ehrlich of Paul Ehrlich: Immunology and cancer research, 1957. ,
Rectal cancer treatment of the elderly, Colorectal Disease, vol.3, issue.6, pp.471-479, 2006. ,
DOI : 10.2165/00002512-200421070-00003
Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer, Gastroenterology Report, vol.2, pp.277-288, 2015. ,
DOI : 10.1007/s11605-015-2814-3
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer, APMIS, vol.67, issue.11, pp.901-908, 2012. ,
DOI : 10.5301/JBM.2008.4500
Digital mRNA profiling, Nature Biotechnology, vol.24, issue.3, pp.293-294, 2008. ,
DOI : 10.1038/nbt0308-293
The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012. ,
DOI : 10.1200/JCO.2010.30.6308
Immunogenic cell death in cancer and infectious disease, Nature Reviews Immunology, vol.16, issue.2, pp.97-111, 2016. ,
DOI : 10.1038/nrc.2016.16
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, 1960. ,
DOI : 10.1126/science.1129139
???? T Cells Provide an Early Source of Interferon ?? in Tumor Immunity, The Journal of Experimental Medicine, vol.65, issue.3, pp.433-442, 2003. ,
DOI : 10.1084/jem.183.4.1681
Occurrence of malignancy in immunodeficiency diseases: A literature review, Cancer, vol.9, issue.91, pp.89-98, 1971. ,
DOI : 10.1097/00007611-195701000-00008
Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer, J. Clin. Oncol, vol.34, pp.3587-3587, 2016. ,
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203, Journal of Clinical Oncology, vol.24, issue.28, pp.4620-4625, 2006. ,
DOI : 10.1200/JCO.2006.06.7629
T Cells to Different Stages of Chemically Induced Skin Cancer, The Journal of Experimental Medicine, vol.156, issue.5, pp.747-755, 2003. ,
DOI : 10.1073/pnas.96.12.6879
Tumor-Infiltrating Cytotoxic T Cells but not Regulatory T Cells Predict Outcome in Anal Squamous Cell Carcinoma, Clinical Cancer Research, vol.12, issue.11, pp.3355-3360, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2434
Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy, Transactions of the ... Meeting of the American Surgical Association, vol.CXXII, issue.&NA;, pp.309-316, 2004. ,
DOI : 10.1097/01.sla.0000141194.27992.32
Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.4, pp.822-828, 2014. ,
DOI : 10.1016/j.ijrobp.2013.12.012
Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer, Diseases of the Colon & Rectum, vol.56, issue.6, pp.698-703, 2013. ,
DOI : 10.1097/DCR.0b013e3182837e5b
Medical Archaeology Coley's toxin: Historical Perspective, 2002. ,
The role of diffusion-weighted MRI and 18F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: A systematic review, Radiotherapy and Oncology, vol.113, issue.2, pp.158-165, 2014. ,
DOI : 10.1016/j.radonc.2014.11.026
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer, New England Journal of Medicine, vol.345, issue.9, pp.638-646, 2001. ,
DOI : 10.1056/NEJMoa010580
T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer, Cancer, vol.116, issue.6, pp.1387-1395, 2008. ,
DOI : 10.1136/bmj.311.7010.899
PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090331
Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level, Medicine, vol.94, issue.31, 2015. ,
DOI : 10.1097/MD.0000000000001291
Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation, Annals of Surgery, vol.234, issue.3, p.352, 2001. ,
DOI : 10.1097/00000658-200109000-00009
What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?, Cancer Research and Treatment, vol.48, issue.3, pp.998-1009, 2016. ,
DOI : 10.4143/crt.2015.254
Tumor Antigens, Annual Review of Microbiology, vol.20, issue.1, pp.223-252, 1966. ,
DOI : 10.1146/annurev.mi.20.100166.001255
Adaptive immunity maintains occult cancer in an equilibrium state, Nature, vol.410, issue.7171, pp.903-907, 2007. ,
DOI : 10.4049/jimmunol.169.7.3667
Shifting concepts in rectal cancer management, CA: A Cancer Journal for Clinicians, vol.50, issue.suppl, pp.173-202, 2012. ,
DOI : 10.1007/s10350-007-277-7
Immunogenic Cell Death in Cancer Therapy, Annual Review of Immunology, vol.31, issue.1, pp.51-72, 2013. ,
DOI : 10.1146/annurev-immunol-032712-100008
Thymic Stromal Lymphopoietin and Cancer, The Journal of Immunology, vol.193, issue.9, 2014. ,
DOI : 10.4049/jimmunol.1400864
Immunology of Experimental Tumors, Annual Review of Medicine, vol.15, issue.1, 1964. ,
DOI : 10.1146/annurev.me.15.020164.001123
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2520, 2015. ,
DOI : 10.1056/NEJMoa1500596
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy, Tumor Biology, vol.93, issue.Pt 3, pp.7675-7683, 2015. ,
DOI : 10.1073/pnas.93.12.5925
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints. Cancer Discov, pp.43-51, 2015. ,
When is local excision appropriate for ???early??? rectal cancer?, Surgery Today, vol.8, issue.suppl, 2000. ,
DOI : 10.1586/14737140.8.1.111
URL : https://link.springer.com/content/pdf/10.1007%2Fs00595-013-0766-3.pdf
The Toxins of William B. Coley and the Treatment of Bone and Soft- Tissue Sarcomas, Iowa Orthop. J, vol.26, pp.154-158, 2006. ,
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease, Nature, vol.256, issue.6871, pp.536-541, 2002. ,
DOI : 10.1038/256495a0
Thymic Stromal Lymphopoietin Is a Key Mediator of Breast Cancer Progression, The Journal of Immunology, vol.186, issue.10, pp.5656-5662, 1950. ,
DOI : 10.4049/jimmunol.1100463
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, New England Journal of Medicine, vol.353, issue.25, pp.2654-2666, 2005. ,
DOI : 10.1056/NEJMoa051424
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009. ,
DOI : 10.1200/JCO.2008.19.6147
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy, International Journal of Oncology, vol.49, issue.2, pp.471-478, 2016. ,
DOI : 10.3892/ijo.2016.3540
PD-1 Restrains Radiotherapy-Induced Abscopal Effect, Cancer Immunology Research, vol.3, issue.6, pp.610-619, 2015. ,
DOI : 10.1158/2326-6066.CIR-14-0138
Magnetic Resonance Imaging???Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience, Journal of Clinical Oncology, vol.29, issue.28, pp.3753-3760, 2011. ,
DOI : 10.1200/JCO.2011.34.9068
Posttransplant malignancies, Transplantation Proceedings, vol.31, issue.1-2, pp.1260-1262, 1999. ,
DOI : 10.1016/S0041-1345(98)01987-3
De Novo Malignant Tumors in Organ Transplant Recipients, Transplant. Proc, vol.3, pp.773-778, 1971. ,
Watch and Wait????Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer, Journal of Gastrointestinal Surgery, vol.31, issue.1, pp.43-52, 2016. ,
DOI : 10.1016/S0360-3016(02)02764-5
Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer, Colorectal Disease, vol.12, issue.12, pp.1353-1360, 2011. ,
DOI : 10.1111/j.1463-1318.2009.02054.x
The mechanism of action of BCG therapy for bladder cancer???a current perspective, Nature Reviews Urology, vol.59, issue.3, pp.153-162, 2014. ,
DOI : 10.1159/000283049
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant, Cancer Treatment Reviews, vol.41, issue.6, pp.503-510, 2015. ,
DOI : 10.1016/j.ctrv.2015.03.011
Séquelles fonctionnelles digestives après chirurgie du cancer du rectum, 2011. ,
IFN? and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, issue.6832, pp.1107-1111, 2001. ,
DOI : 10.1038/35074122
The CD4-like molecule LAG-3, biology and therapeutic applications, Expert Opinion on Therapeutic Targets, vol.11, issue.1, pp.91-101, 2011. ,
DOI : 10.1016/S1470-2045(09)70334-1
Clinical Significance of Acellular Mucin in Rectal Adenocarcinoma Patients With a Pathologic Complete Response to Preoperative Chemoradiation, Annals of Surgery, vol.251, issue.2, pp.261-264, 2010. ,
DOI : 10.1097/SLA.0b013e3181bdfc27
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma, International Immunology, vol.13, issue.4, pp.459-463, 2001. ,
DOI : 10.1084/jem.192.5.741
Complications and risk prediction in treatment of elderly patients with rectal cancer, International Journal of Colorectal Disease, vol.8, issue.17, pp.87-93, 2016. ,
DOI : 10.1016/S1470-2045(07)70045-1
Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy, Oncotarget, vol.7, issue.43, pp.69507-69517, 2016. ,
DOI : 10.18632/oncotarget.10875
Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma, Cancer Research, vol.76, issue.21, pp.6241-6252, 2016. ,
DOI : 10.1158/0008-5472.CAN-16-0992
Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer, Am. J. Cancer Res, vol.5, pp.2064-2074, 2015. ,
Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment. Front, Oncol, vol.3, 2013. ,
Cellular and Humoral Aspects of Hypersensitivity, 1959. ,
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations, Modern Pathology, vol.30, issue.9, pp.1186-1195, 2009. ,
DOI : 10.1371/journal.pone.0002583
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer, Nature, vol.67, issue.7547, pp.373-377, 2015. ,
DOI : 10.1007/s00285-012-0589-7
Baseline tumor T cell receptor (TcR) sequencing analysis and neo antigen load is associated with benefit in melanoma patients receiving sequential nivolumab and ipilimumab, Annals of Oncology, vol.27, issue.suppl_6, 2016. ,
DOI : 10.1093/annonc/mdw378.01
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective, Pharmacology & Therapeutics, vol.64, issue.3, pp.529-564, 1994. ,
DOI : 10.1016/0163-7258(94)90023-X
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer, Radiation Oncology, vol.6, issue.1, p.49, 2011. ,
DOI : 10.1038/nm1622
Local Excision: Is It an Adequate Substitute for Radical Resection in T1/T2 Patients?, Seminars in Radiation Oncology, vol.21, issue.3, pp.178-184, 2011. ,
DOI : 10.1016/j.semradonc.2011.02.003
Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma, International Journal of Cancer, vol.65, issue.6, pp.1498-1502, 2015. ,
DOI : 10.1136/jclinpath-2012-200958
Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer, Chinese Journal of Cancer, vol.30, issue.14, p.41, 2015. ,
DOI : 10.1200/JCO.2011.39.6036
Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.59-73, 2008. ,
DOI : 10.4049/jimmunol.172.4.2039
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance, Immunity, vol.39, issue.1, pp.74-88, 2013. ,
DOI : 10.1016/j.immuni.2013.06.014